Dermata Therapeutics Inc Share Price Today: Live Updates & Key Insights

Dermata Therapeutics Inc share price today is $1.3, up 4.76%. The stock opened at $1.27 against the previous close of $1.26, with an intraday high of $1.34 and low of $1.26.

Dermata Therapeutics Inc Share Price Chart

Dermata Therapeutics Inc

us-stock
To Invest in {{usstockname}}
us-stock

Dermata Therapeutics Inc Share Price Performance

$1.3 0.0476(4.76%) DRMA at 27 Jul 2026 02:44 PM Biotechnology
Lowest Today 1.26
Highest Today 1.34
Today’s Open 1.27
Prev. Close 1.26
52 Week High 7.33
52 Week Low 1.10
Day’s Range: Low 1.26 High 1.34
52-Week Range: Low 1.10 High 7.33
1 day return -
1 Week return -
1 month return +0.39
3 month return +6.66
6 month return -58.03
1 year return -79.84
3 year return -94.38
5 year return -99.89
10 year return -

Dermata Therapeutics Inc Institutional Holdings

Geode Capital Management, LLC 1.20

Fidelity Extended Market Index 1.03

UBS Group AG 0.89

Welch & Forbes LLC 0.50

NT Ext Equity Mkt Index Fund - NL 0.07

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.05

Mcf Advisors, LLC 0.04

Fidelity Series Total Market Index 0.03

Tower Research Capital LLC 0.02

Spartan Extended Market Index Pool F 0.00

SBI Securities Co Ltd 0.00

Armistice Capital, LLC 0.00

Bank of America Corp 0.00

Barclays PLC 0.00

Citigroup Inc 0.00

Clear Street Group Inc 0.00

JPMorgan Chase & Co 0.00

Dermata Therapeutics Inc Market Status

Strong Buy: 0

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Dermata Therapeutics Inc Fundamentals

Market Cap 5.07 M

PB Ratio 0.7965

PE Ratio 0.0

Enterprise Value -1.84 M

Total Assets 7.86 M

Volume 83120

Dermata Therapeutics Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-7330319 -7.3M, FY22:-9610913 -9.6M, FY21:-7948090 -7.9M, FY20:-3433799 -3.4M, FY19:-4972104 -5.0M

Quarterly Revenue Q1/2026:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M

Quarterly Profit Q1/2026:null 0.0M, Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M

Quarterly Net worth Q1/2026:-1847706 -1.8M, Q3/2025:-1691989 -1.7M, Q2/2025:-1701093 -1.7M, Q1/2025:-2303587 -2.3M, Q3/2024:-3173156 -3.2M

About Dermata Therapeutics Inc & investment objective

Company Information Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Organisation Biotechnology

Employees 9

Industry Biotechnology

CEO Mr. Gerald T. Proehl

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Dermata Therapeutics Inc FAQs

What is the share price of Dermata Therapeutics Inc today?

The current share price of Dermata Therapeutics Inc is $1.3.

Can I buy Dermata Therapeutics Inc shares in India?

Yes, Indian investors can buy Dermata Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Dermata Therapeutics Inc shares in India?

You can easily invest in Dermata Therapeutics Inc shares from India by:

Can I buy fractional shares of Dermata Therapeutics Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Dermata Therapeutics Inc?

Dermata Therapeutics Inc has a market cap of $5.07 M.

In which sector does Dermata Therapeutics Inc belong?

Dermata Therapeutics Inc operates in the Biotechnology sector.

What documents are required to invest in Dermata Therapeutics Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Dermata Therapeutics Inc?

The PE ratio of Dermata Therapeutics Inc is N/A and the PB ratio is 0.80.